Bharat Rasayan Limited (BHARATRAS.NS)
New Delhi, IN
Established in 1989 and headquartered in New Delhi, India, Bharat Rasayan Limited is a key producer and distributor of agrochemical products. The company specializes in technical grade pesticides, encompassing insecticides, herbicides, and fungicides, alongside chemical intermediates and bulk formulations. Bharat Rasayan serves the Indian market and also engages in the export of its diverse product range.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.66% | +6.63% | +6.76% | -1.43% | -42.52% | -33.27% | -40.22% | -42.02% | -50.84% | +435.02% | +17,988.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+5.9% Q1'26: +0.5% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-48.3% Q1'26: -24.1% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+7.6% Q1'26: -5.3% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+13.9% ★ Q1'26: +14.1% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+13.0% ★ Q1'26: +12.8% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+100.0% Q1'26: +100.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.01× ★ Q1'26: 0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.39B
est: 5.06B (-13.3%)
|
4.56B
est: 4.59B (-0.9%)
|
6.12B
est: 6.30B (-2.8%)
|
7.89B
est: 7.63B (+3.3%)
|
9.83B
est: 10.21B (-3.7%)
|
12.15B
est: 12.35B (-1.6%)
|
10.80B
est: 14.45B (-25.2%)
|
12.95B
est: 17.20B (-24.7%)
|
12.34B
est: 20.46B (-39.7%)
|
11.73B
est: 4.59B (+155.3%)
|
4.59B
4.59B – 4.59B
+0.0% YoY
|
6.30B
6.30B – 6.30B
+37.1% YoY
|
7.63B
7.63B – 7.63B
+21.2% YoY
|
10.21B
10.21B – 10.21B
+33.7% YoY
|
12.35B
12.35B – 12.35B
+21.0% YoY
|
14.45B
14.45B – 14.45B
+17.0% YoY
|
| EBITDA |
823.13M
est: 913.33M (-9.9%)
|
811.45M
est: 829.38M (-2.2%)
|
1.13B
est: 1.14B (-0.7%)
|
1.63B
est: 1.38B (+18.5%)
|
1.88B
est: 1.84B (+2.0%)
|
2.43B
est: 2.23B (+9.1%)
|
2.45B
est: 2.61B (-6.2%)
|
2.66B
est: 2.94B (-9.6%)
|
2.06B
est: 3.71B (-44.5%)
|
2.01B
est: 829.38M (+142.4%)
|
829.38M
829.38M – 829.38M
+0.0% YoY
|
1.14B
1.14B – 1.14B
+37.1% YoY
|
1.38B
1.38B – 1.38B
+21.2% YoY
|
1.84B
1.84B – 1.84B
+33.7% YoY
|
2.23B
2.23B – 2.23B
+21.0% YoY
|
2.61B
2.61B – 2.61B
+17.0% YoY
|
| EBIT |
645.02M
est: 800.12M (-19.4%)
|
640.25M
est: 726.58M (-11.9%)
|
963.75M
est: 996.14M (-3.3%)
|
1.46B
est: 1.21B (+21.1%)
|
1.71B
est: 1.61B (+5.9%)
|
2.21B
est: 1.95B (+13.0%)
|
2.19B
est: 2.29B (-4.2%)
|
2.40B
est: 2.84B (-15.3%)
|
1.80B
est: 3.25B (-44.7%)
|
1.74B
est: 726.58M (+139.4%)
|
726.58M
726.58M – 726.58M
+0.0% YoY
|
996.14M
996.14M – 996.14M
+37.1% YoY
|
1.21B
1.21B – 1.21B
+21.2% YoY
|
1.61B
1.61B – 1.61B
+33.7% YoY
|
1.95B
1.95B – 1.95B
+21.0% YoY
|
2.29B
2.29B – 2.29B
+17.0% YoY
|
| Net Income |
317.49M
est: 707.47M (-55.1%)
|
338.76M
est: 703.15M (-51.8%)
|
545.34M
est: 1.03B (-46.9%)
|
983.14M
est: 1.44B (-31.7%)
|
1.12B
est: 2.33B (-52.1%)
|
1.58B
est: 3.05B (-48.3%)
|
1.64B
est: 3.63B (-54.9%)
|
1.76B
est: 2.19B (-19.8%)
|
1.25B
est: 5.71B (-78.2%)
|
1.41B
est: 703.15M (+100.4%)
|
175.79M
175.79M – 175.79M
-75.0% YoY
|
256.83M
256.83M – 256.83M
+46.1% YoY
|
359.99M
359.99M – 359.99M
+40.2% YoY
|
582.21M
582.21M – 582.21M
+61.7% YoY
|
762.57M
762.57M – 762.57M
+31.0% YoY
|
908.39M
908.39M – 908.39M
+19.1% YoY
|
| SGA |
139.98M
est: 371.15M (-62.3%)
|
167.77M
est: 337.04M (-50.2%)
|
132.52M
est: 462.09M (-71.3%)
|
157.86M
est: 560.07M (-71.8%)
|
178.21M
est: 749.08M (-76.2%)
|
179.97M
est: 906.19M (-80.1%)
|
815.77M
est: 1.06B (-23.1%)
|
263.33M
est: 1.26B (-79.0%)
|
888.31M
est: 1.50B (-40.6%)
|
1.36B
est: 337.04M (+302.9%)
|
337.04M
337.04M – 337.04M
+0.0% YoY
|
462.09M
462.09M – 462.09M
+37.1% YoY
|
560.07M
560.07M – 560.07M
+21.2% YoY
|
749.08M
749.08M – 749.08M
+33.7% YoY
|
906.19M
906.19M – 906.19M
+21.0% YoY
|
1.06B
1.06B – 1.06B
+17.0% YoY
|
| EPS |
37.37
est: 85.13 (-56.1%)
|
39.87
est: 84.61 (-52.9%)
|
64.18
est: 123.62 (-48.1%)
|
115.69
est: 173.27 (-33.2%)
|
131.24
est: 280.23 (-53.2%)
|
185.51
est: 367.04 (-49.5%)
|
192.84
est: 437.23 (-55.9%)
|
211.78
est: 546.76 (-61.3%)
|
149.95
est: 683.73 (-78.1%)
|
169.57
est: 84.61 (+100.4%)
|
21.15
21.15 – 21.15
-75.0% YoY
|
30.91
30.91 – 30.91
+46.1% YoY
|
43.32
43.32 – 43.32
+40.2% YoY
|
70.06
70.06 – 70.06
+61.7% YoY
|
91.76
91.76 – 91.76
+31.0% YoY
|
109.31
109.31 – 109.31
+19.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ajay Kumar Gupta | Whole Time Director & Director of Operations | 10M | male |
| Kamleshwar Prasad Uniyal | Director of Operations & Executive Director | 5M | male |
| Rakesh Kumar Verma | Chief Financial Officer | 2M | male |
| Mahabir Prasad Gupta | Whole Time Director | 2M | male |
| Rajender Prasad Gupta | Non-Executive & Non-Independent Director | 1M | male |
| Nikita Chadha | Company Secretary & Compliance Officer | 898.0K | female |
| Sat Narain Gupta | Chairman & MD | — | male |
| Mangal Rama Chandrudu | Assistant Vice President of Operations | — | — |
| Prashant Yuvraj Patil | Associate Vice President of Operations | — | — |
| Abhishek Aggarwal | President & Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BHARATRAS.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
